Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $12,689,749 |
Sells | 22 | $4,443,399 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 May 2024 21:00 | AUGX | Augmedix Inc | CHATTERJEE SAURAV | CHIEF TECHNOLOGY OFFICER | 15 May 2024 | Sale | 1,767 | 1.19 | 2,103 | D |
17 May 2024 21:00 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 15 May 2024 | Sale | 1,387 | 1.19 | 1,651 | D |
17 May 2024 21:00 | AUGX | Augmedix Inc | GINOCCHIO PAUL | CHIEF FINANCIAL OFFICER | 15 May 2024 | Sale | 2,354 | 1.19 | 2,801 | D |
17 May 2024 21:00 | AUGX | Augmedix Inc | HAWKINS JONATHAN | CHIEF REVENUE OFFICER | 15 May 2024 | Sale | 1,767 | 1.19 | 2,103 | D |
17 May 2024 21:00 | AUGX | Augmedix Inc | KRAKARIS EMMANUEL | PRESIDENT, CEO, AND SECRETARY | 15 May 2024 | Sale | 3,528 | 1.19 | 4,198 | D |
17 May 2024 21:00 | AUGX | Augmedix Inc | BREBER SANDRA | CHIEF OPERATING OFFICER | 15 May 2024 | Sale | 2,354 | 1.19 | 2,801 | D |
16 Apr 2024 21:07 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 15 Apr 2024 | Sale | 500 | 3.8 | 1,900 | D |
15 Apr 2024 21:15 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 12 Apr 2024 | Sale | 19,544 | 3.8165 | 74,590 | D |
11 Apr 2024 20:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 11 Apr 2024 | Sale | 24,778 | 3.934 | 97,477 | D |
11 Apr 2024 20:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 10 Apr 2024 | Sale | 36,467 | 3.8744 | 141,288 | D |
11 Apr 2024 20:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 09 Apr 2024 | Sale | 31,542 | 4.138 | 130,521 | D |
09 Apr 2024 20:49 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 08 Apr 2024 | Sale | 28,563 | 3.9695 | 113,381 | D |
09 Apr 2024 20:49 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 08 Apr 2024 | Sale | 9,217 | 3.9695 | 36,587 | D |
09 Apr 2024 20:49 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 05 Apr 2024 | Sale | 51,387 | 4.0328 | 207,233 | D |
09 Apr 2024 20:47 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 28 Mar 2024 | Sale A | 31,994 | 4.0586 | 129,851 | D |
04 Apr 2024 20:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 04 Apr 2024 | Sale | 64,055 | 4.1504 | 265,854 | D |
04 Apr 2024 20:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 03 Apr 2024 | Sale | 45,906 | 4.1084 | 188,600 | D |
03 Apr 2024 21:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 02 Apr 2024 | Sale | 38,463 | 3.8927 | 149,725 | D |
03 Apr 2024 21:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 01 Apr 2024 | Sale | 7,632 | 4.0224 | 30,699 | D |
03 Apr 2024 21:30 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 01 Apr 2024 | Sale | 51,346 | 3.889 | 199,685 | D |
01 Apr 2024 20:28 | AUGX | Augmedix Inc | SHAKIL IAN | CHIEF STRATEGY OFFICER | 28 Mar 2024 | Sale | 31,994 | 4.0586 | 129,851 | D |
27 Nov 2023 07:00 | AUGX | Augmedix Inc | GINOCCHIO PAUL | CHIEF FINANCIAL OFFICER | 22 Nov 2023 | Purchase | 10,000 | 4.85 | 48,500 | D |
22 Nov 2023 16:15 | AUGX | Augmedix Inc | REDMILE GROUP, LLC | Director , 10% | 20 Nov 2023 | Purchase | 750,000 | 4 | 3,000,000 | D |
22 Nov 2023 16:15 | AUGX | Augmedix Inc | REDMILE GROUP, LLC | Director , 10% | 20 Nov 2023 | Purchase | 750,000 | 4 | 3,000,000 | I |
16 Jun 2023 17:50 | AUGX | Augmedix Inc | TRAYLOR MARGIE L. | Director | 14 Jun 2023 | Purchase | 26,529.8 | 4.51 | 119,649 | D |
21 Apr 2023 21:53 | AUGX | Augmedix Inc | REDMILE GROUP, LLC | Director , 10% | 28 Oct 2021 | Purchase A | 1,625,000 | 4 | 6,500,000 | D |
15 Dec 2022 16:10 | AUGX | Augmedix Inc | MCKESSON VENTURES, LLC | Former 10% Owner | 13 Dec 2022 | Sale | 2,410,000 | 1.05 | 2,530,500 | D |
15 Dec 2022 16:06 | AUGX | Augmedix Inc | GINOCCHIO PAUL | CHIEF FINANCIAL OFFICER | 13 Dec 2022 | Purchase | 18,000 | 1.2 | 21,600 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)